Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Astellas
Biotech
Bayer to take menopause drug to regulators after 3rd ph. 3 win
Bayer's hot flash drug has struck phase 3 gold again, setting up the pharma to approach regulators about following Astellas’ Veozah to market.
James Waldron
Mar 19, 2024 7:17am
Astellas puts the cork back in $350M Xork deal with Cartesian
Mar 14, 2024 10:41am
Bayer hits hot flash phase 3 goals to stay on Astellas’ heels
Jan 8, 2024 10:16am
Phenomic inks 2nd deal in 2 days, Shape adds to Roche pact
Nov 30, 2023 10:14am
Astellas pays $175M for Propella to snag rival to J&J's Zytiga
Nov 16, 2023 7:18am
Astellas finds underlying liver issues in gene therapy deaths
Nov 16, 2023 7:12am